282 related articles for article (PubMed ID: 30550388)
1. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
Maki KC; Dicklin MR
Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):116-123. PubMed ID: 30550388
[TBL] [Abstract][Full Text] [Related]
2. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
[TBL] [Abstract][Full Text] [Related]
3. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
[TBL] [Abstract][Full Text] [Related]
4. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
[TBL] [Abstract][Full Text] [Related]
5. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
[TBL] [Abstract][Full Text] [Related]
6. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
[TBL] [Abstract][Full Text] [Related]
7. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T
J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197
[TBL] [Abstract][Full Text] [Related]
8. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
Galli C; Maggi FM; Risé P; Sirtori CR
Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance.
Maki KC; Johns C; Harris WS; Puder M; Freedman SD; Thorsteinsson T; Daak A; Rabinowicz AL; Sancilio FD
Clin Ther; 2017 Mar; 39(3):652-658. PubMed ID: 28189365
[TBL] [Abstract][Full Text] [Related]
11. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.
Krokan HE; Bjerve KS; Mørk E
Biochim Biophys Acta; 1993 May; 1168(1):59-67. PubMed ID: 8504143
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
[TBL] [Abstract][Full Text] [Related]
14. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.
Fialkow J
Am J Cardiovasc Drugs; 2016 Aug; 16(4):229-239. PubMed ID: 27138439
[TBL] [Abstract][Full Text] [Related]
16. A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults.
Bremmell KE; Briskey D; Meola TR; Mallard A; Prestidge CA; Rao A
Eur J Nutr; 2020 Sep; 59(6):2729-2737. PubMed ID: 31637467
[TBL] [Abstract][Full Text] [Related]
17. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters.
Bryhn M; Hansteen H; Schanche T; Aakre SE
Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):19-24. PubMed ID: 16806871
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
[TBL] [Abstract][Full Text] [Related]
19. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.
Neubronner J; Schuchardt JP; Kressel G; Merkel M; von Schacky C; Hahn A
Eur J Clin Nutr; 2011 Feb; 65(2):247-54. PubMed ID: 21063431
[TBL] [Abstract][Full Text] [Related]
20. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
